Literature DB >> 2138892

Detection of soluble forms of the beta-amyloid precursor protein in human plasma.

M B Podlisny1, A L Mammen, M G Schlossmacher, M R Palmert, S G Younkin, D J Selkoe.   

Abstract

A approximately 40-residue fragment of the beta-amyloid precursor protein (APP) is progressively deposited in the extracellular spaces of brain and blood vessels in Alzheimer's disease (AD), Down's syndrome and aged normal subjects. Soluble, truncated forms of APP lacking the carboxyl terminus are normally secreted from cultured cells expressing this protein and are found in cerebrospinal fluid. Here, we report the detection of a similar soluble APP isoform in human plasma. This approximately 125 kDa protein, which was isolated from plasma by Affi-Gel Blue chromatography or dialysis-induced precipitation, comigrates with the larger of the two major soluble APP forms present in spinal fluid and contains the Kunitz protease inhibitor insert. It thus derives from the APP751 and APP770 precursors; a soluble form of APP695 has not yet been detected in plasma. The approximately 125 kDa plasma form lacks the C-terminal region and is unlikely to serve as a precursor for the beta-protein that forms the amyloid in AD.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2138892     DOI: 10.1016/0006-291x(90)90635-z

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Relationship of amyloid to Alzheimer's disease.

Authors:  H V Vinters
Journal:  West J Med       Date:  1991-01

2.  Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer's disease. An immunoelectron microscopic study.

Authors:  H Yamaguchi; T Yamazaki; C A Lemere; M P Frosch; D J Selkoe
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

Review 3.  The role of exosomes in the processing of proteins associated with neurodegenerative diseases.

Authors:  Laura J Vella; Robyn A Sharples; Rebecca M Nisbet; Roberto Cappai; Andrew F Hill
Journal:  Eur Biophys J       Date:  2007-12-07       Impact factor: 1.733

Review 4.  The role of beta-amyloid peptide in Alzheimer's disease.

Authors:  A LeBlanc
Journal:  Metab Brain Dis       Date:  1994-03       Impact factor: 3.584

5.  Exosomes Secreted from HEK293-APP Swe/Ind Cells Impair the Hippocampal Neurogenesis.

Authors:  Tingting Zheng; Jiali Pu; Yanxing Chen; Zhangyu Guo; Hongyu Pan; Ling Zhang; Heng Zhang; Binggui Sun; Baorong Zhang
Journal:  Neurotox Res       Date:  2017-03-21       Impact factor: 3.911

6.  P3 beta-amyloid peptide has a unique and potentially pathogenic immunohistochemical profile in Alzheimer's disease brain.

Authors:  L S Higgins; G M Murphy; L S Forno; R Catalano; B Cordell
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

7.  Homology of the amyloid beta protein precursor in monkey and human supports a primate model for beta amyloidosis in Alzheimer's disease.

Authors:  M B Podlisny; D R Tolan; D J Selkoe
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

Review 8.  Measuring target effect of proposed disease-modifying therapies in Alzheimer's disease.

Authors:  Randall J Bateman; William E Klunk
Journal:  Neurotherapeutics       Date:  2008-07       Impact factor: 7.620

9.  The spatial patterns of beta/A4 deposit subtypes in Down's syndrome.

Authors:  R A Amstrong
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

10.  The spatial patterns of beta/A4 deposit subtypes in Alzheimer's disease.

Authors:  R A Armstrong; D Myers; C U Smith
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.